Correlation Between Neurobo Pharmaceuticals and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Indaptus Therapeutics, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Indaptus Therapeutics.
Diversification Opportunities for Neurobo Pharmaceuticals and Indaptus Therapeutics
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Neurobo and Indaptus is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and Indaptus Therapeutics
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to under-perform the Indaptus Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Neurobo Pharmaceuticals is 1.28 times less risky than Indaptus Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Indaptus Therapeutics is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 122.00 in Indaptus Therapeutics on October 24, 2024 and sell it today you would lose (36.00) from holding Indaptus Therapeutics or give up 29.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 88.89% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. Indaptus Therapeutics
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Indaptus Therapeutics |
Neurobo Pharmaceuticals and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and Indaptus Therapeutics
The main advantage of trading using opposite Neurobo Pharmaceuticals and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |